Pipernonaline



Compound IDCDAMM00360
Common namePipernonaline
IUPAC name(2E,8E)-9-(1,3-benzodioxol-5-yl)-1-piperidin-1-ylnona-2,8-dien-1-one
Molecular formulaC21H27NO3

Experimental data

Retention time44.349
Adduct[M+H]+
Actual mz342.206
Theoretical mz342.206
Error0.29
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.7

Identifiers and class information

Inchi keyPKLGRWSJBLGIBF-JMQWPVDRSA-N
SmilesO=C(C=CCCCCC=CC1=CC=C2OCOC2=C1)N3CCCCC3
SuperclassOrganoheterocyclic compounds
ClassBenzodioxoles

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)0
Molecular weight (mol_MW)341.449
Computed dipole moment(dipole)3.584
Total solvent accessible surface area (SASA)687.489
Hydrophobic component of SASA (FOSA)482.932
Hydrophilic component of SASA (FISA)38.873
Pie component of the SASA (PISA)165.684
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1200.57
Number of hydrogen bond donors (donorHB)0
Number of hydrogen bond acceptors (accptHB)4.5
Free energy of solvation of dipole (dip^2/V)0.0106984
Index of cohesive interaction in solids (ACxDN^.5/SA)0
Globularity descriptor (glob)0.794616
Predicted polarizability in cubic angstroms (QPpolrz)38.98
Predicted hexadecane/gas partition coefficient (QPlogPC16)10.846
Predicted octanol/gas partition coefficient (QPlogPoct)14.616
Predicted water/gas partition coefficient (QPlogPw)5.653
Predicted octanol/water partition coefficient (QPlogPo/w)4.861
Predicted aqueous solubility (QPlogS)-5.749
Conformation-independent predicted aqueous solubility (CIQPlogS)-4.747
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.645
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)4239.07
Predicted brain/blood partition coefficient (QPlogBB)-0.269
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)2356.98
Predicted skin permeability, log Kp (QPlogKp)-0.98
PM3 calculated ionization potential (IP(ev))8.754
PM3 calculated electron affinity (EA(eV))0.317
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)0.602
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)47.108
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q8NER1TRPV1Vanilloid receptorT83193SEA
P20701ITGALIntercellular adhesion molecule (ICAM-1), Integrin alpha-L/beta-2T35640SEA
P05362ICAM1Intercellular adhesion molecule-1T26203SEA
Q15078CDK5R1Cyclin-dependent kinase 5/CDK5 activator 1T09513SEA
Q00535CDK5Cyclin-dependent kinase 5/CDK5 activator 1T20973SEA
O75908SOAT2Acyl coenzyme A:cholesterol acyltransferase 2T14463SwissTargetPrediction
O60344ECE2Endothelin-converting enzyme 2T16799SEA
Q92630DYRK2Dual-specificity tyrosine-phosphorylation regulated kinase 2T39486SEA
P32249EBI2EBV-induced G-protein coupled receptor 2T59577SEA
Q7RTX1TAS1R1Taste receptorT41263SEA
Q15717ELAVL1ELAV-like protein 1T78349SEA
P05107ITGB2Integrin beta-2T10513SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T83193DI0163General pain disorder[ICD-11: 8E43]Q8NER1TRPV1
T35640DI0351Psoriasis[ICD-11: EA90]P20701ITGAL
T35640DI0436Visual system disease[ICD-11: 9E1Z]P20701ITGAL
T26203DI0436Visual system disease[ICD-11: 9E1Z]P05362ICAM1
T20973DI0308Obesity[ICD-11: 5B80-5B81]Q00535CDK5
T14463DI0017Adrenal cancer[ICD-11: 2D11]O75908SOAT2
T41263DI0078Cholera[ICD-11: 1A00]Q7RTX1TAS1R1
T10513DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P05107ITGB2

Copyright © 2025